Anti-Dog CD22 Polyclonal Antibody

Anti-Dog CD22 Polyclonal Antibody: A Powerful Tool for Studying B-Cell Development and Function

Introduction:
The Anti-Dog CD22 Polyclonal Antibody is a highly specific and sensitive tool for studying B-cell development and function in dogs. This antibody targets the CD22 protein, a cell surface receptor that is primarily expressed on B-cells and is involved in regulating B-cell activation and proliferation. With its high affinity and specificity, this antibody is an essential tool for researchers in the field of biotechnology and immunology.

Biological Function:
The CD22 protein is a member of the sialic acid-binding immunoglobulin-like lectin (Siglec) family, and it plays a crucial role in the regulation of B-cell function. It acts as an inhibitory receptor, controlling the activation of B-cells by binding to sialic acid-containing glycoproteins on the surface of other cells. This interaction helps maintain the balance between immune tolerance and immune response, making CD22 an essential regulator of the immune system.

Main Applications:
The Anti-Dog CD22 Polyclonal Antibody is a valuable tool for a wide range of applications, including flow cytometry, immunohistochemistry, and immunofluorescence. It allows for the specific detection and isolation of B-cells in various tissues and cell cultures, making it an essential tool for studying the development and function of B-cells in both healthy and diseased states. Additionally, this antibody can be used for therapeutic purposes, such as targeting and depleting B-cells in autoimmune diseases and B-cell malignancies.

Experimental Use Cases:
The Anti-Dog CD22 Polyclonal Antibody has been extensively used in various research studies and has shown promising results. In one study, it was used to identify and isolate B-cells from the peripheral blood of dogs with lymphoma, allowing for a better understanding of the disease and its progression. In another study, this antibody was used to investigate the role of CD22 in the development of B-cell lymphomas, providing valuable insights into potential therapeutic targets for these cancers.

Conclusion:
In conclusion, the Anti-Dog CD22 Polyclonal Antibody is an essential tool for studying B-cell development and function in dogs. Its high specificity and sensitivity make it a valuable asset for researchers in the field of biotechnology and immunology. With its various applications and promising results in experimental studies, this antibody is a must-have for any laboratory studying B-cell-related diseases or therapies.

Keywords: Anti-Dog CD22 Polyclonal Antibody, B-cell development, B-cell function, CD22 protein, Siglec family, immune tolerance, immune response, flow cytometry, immunohistochemistry, immunofluorescence, autoimmune diseases, B-cell malignancies, lymphoma, therapeutic targets, biotechnology, immunology.